NASDAQ:HOWL | Insider Transactions — Page 5 | Werewolf Therapeutics, Inc.

HOWL Insider Transactions — Page 5

587 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 401–500; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
MPM BioVentures 2014 (B), L.P.TenPercentOwner2025-11-05Sale47,950.0$1.22
MPM Asset Management Investors BV2014 LLCTenPercentOwner2025-11-05Sale47,950.0$1.22
MPM BioVentures 2014 LLCTenPercentOwner2025-11-05Sale47,950.0$1.22
MPM BioVentures 2014 GP LLCTenPercentOwner2025-11-05Sale47,950.0$1.22
GADICKE ANSBERTTenPercentOwner2025-11-05Sale47,950.0$1.22
MPM ASSET MANAGEMENT LLCTenPercentOwner2025-11-05Sale47,950.0$1.22
MPM BioImpact LLCTenPercentOwner2025-11-05Sale47,950.0$1.22
UBS Oncology Impact Fund L.P.TenPercentOwner2025-11-05Sale47,950.0$1.22
MPM ONCOLOGY INNOVATIONS FUND LPTenPercentOwner2025-11-05Sale47,950.0$1.22
Oncology Impact Fund (Cayman) Management L.P.TenPercentOwner2025-11-05Sale47,950.0$1.22
MPM Oncology Innovations Fund GP LLCTenPercentOwner2025-11-05Sale47,950.0$1.22
EVNIN LUKEDirector2025-11-05Sale30,774.0$1.22
MPM BioVentures 2014, L.P.TenPercentOwner2025-11-04Sale140,488.0$1.22
MPM BioVentures 2014 (B), L.P.TenPercentOwner2025-11-04Sale140,488.0$1.22
MPM Asset Management Investors BV2014 LLCTenPercentOwner2025-11-04Sale140,488.0$1.22
MPM BioVentures 2014 LLCTenPercentOwner2025-11-04Sale140,488.0$1.22
MPM BioVentures 2014 GP LLCTenPercentOwner2025-11-04Sale140,488.0$1.22
GADICKE ANSBERTTenPercentOwner2025-11-04Sale140,488.0$1.22
MPM ASSET MANAGEMENT LLCTenPercentOwner2025-11-04Sale140,488.0$1.22
MPM BioImpact LLCTenPercentOwner2025-11-04Sale140,488.0$1.22
UBS Oncology Impact Fund L.P.TenPercentOwner2025-11-04Sale140,488.0$1.22
MPM ONCOLOGY INNOVATIONS FUND LPTenPercentOwner2025-11-04Sale140,488.0$1.22
Oncology Impact Fund (Cayman) Management L.P.TenPercentOwner2025-11-04Sale140,488.0$1.22
MPM Oncology Innovations Fund GP LLCTenPercentOwner2025-11-04Sale140,488.0$1.22
EVNIN LUKEDirector2025-11-04Sale90,164.0$1.22
MPM BioVentures 2014, L.P.TenPercentOwner2025-11-03Sale94,063.0$1.29
MPM BioVentures 2014 (B), L.P.TenPercentOwner2025-11-03Sale94,063.0$1.29
MPM Asset Management Investors BV2014 LLCTenPercentOwner2025-11-03Sale94,063.0$1.29
MPM BioVentures 2014 LLCTenPercentOwner2025-11-03Sale94,063.0$1.29
MPM BioVentures 2014 GP LLCTenPercentOwner2025-11-03Sale94,063.0$1.29
GADICKE ANSBERTTenPercentOwner2025-11-03Sale94,063.0$1.29
MPM ASSET MANAGEMENT LLCTenPercentOwner2025-11-03Sale94,063.0$1.29
MPM BioImpact LLCTenPercentOwner2025-11-03Sale94,063.0$1.29
UBS Oncology Impact Fund L.P.TenPercentOwner2025-11-03Sale94,063.0$1.29
MPM ONCOLOGY INNOVATIONS FUND LPTenPercentOwner2025-11-03Sale94,063.0$1.29
Oncology Impact Fund (Cayman) Management L.P.TenPercentOwner2025-11-03Sale94,063.0$1.29
MPM Oncology Innovations Fund GP LLCTenPercentOwner2025-11-03Sale94,063.0$1.29
EVNIN LUKEDirector2025-11-03Sale60,369.0$1.29
MPM BioVentures 2014, L.P.TenPercentOwner2025-10-31Sale114,044.0$1.28
MPM BioVentures 2014 (B), L.P.TenPercentOwner2025-10-31Sale114,044.0$1.28
MPM Asset Management Investors BV2014 LLCTenPercentOwner2025-10-31Sale114,044.0$1.28
MPM BioVentures 2014 LLCTenPercentOwner2025-10-31Sale114,044.0$1.28
MPM BioVentures 2014 GP LLCTenPercentOwner2025-10-31Sale114,044.0$1.28
GADICKE ANSBERTTenPercentOwner2025-10-31Sale114,044.0$1.28
MPM ASSET MANAGEMENT LLCTenPercentOwner2025-10-31Sale114,044.0$1.28
MPM BioImpact LLCTenPercentOwner2025-10-31Sale114,044.0$1.28
UBS Oncology Impact Fund L.P.TenPercentOwner2025-10-31Sale114,044.0$1.28
MPM ONCOLOGY INNOVATIONS FUND LPTenPercentOwner2025-10-31Sale114,044.0$1.28
Oncology Impact Fund (Cayman) Management L.P.TenPercentOwner2025-10-31Sale114,044.0$1.28
MPM Oncology Innovations Fund GP LLCTenPercentOwner2025-10-31Sale114,044.0$1.28
EVNIN LUKEDirector2025-10-31Sale73,192.0$1.28
MPM BioVentures 2014, L.P.TenPercentOwner2025-10-30Sale86,936.0$1.43
MPM BioVentures 2014 (B), L.P.TenPercentOwner2025-10-30Sale86,936.0$1.43
MPM Asset Management Investors BV2014 LLCTenPercentOwner2025-10-30Sale86,936.0$1.43
MPM BioVentures 2014 LLCTenPercentOwner2025-10-30Sale86,936.0$1.43
MPM BioVentures 2014 GP LLCTenPercentOwner2025-10-30Sale86,936.0$1.43
GADICKE ANSBERTTenPercentOwner2025-10-30Sale86,936.0$1.43
MPM ASSET MANAGEMENT LLCTenPercentOwner2025-10-30Sale86,936.0$1.43
MPM BioImpact LLCTenPercentOwner2025-10-30Sale86,936.0$1.43
UBS Oncology Impact Fund L.P.TenPercentOwner2025-10-30Sale86,936.0$1.43
MPM ONCOLOGY INNOVATIONS FUND LPTenPercentOwner2025-10-30Sale86,936.0$1.43
Oncology Impact Fund (Cayman) Management L.P.TenPercentOwner2025-10-30Sale86,936.0$1.43
MPM Oncology Innovations Fund GP LLCTenPercentOwner2025-10-30Sale86,936.0$1.43
EVNIN LUKEDirector2025-10-30Sale55,795.0$1.43
EVNIN LUKEDirector2025-10-29Sale86,154.0$1.55
MPM BioVentures 2014, L.P.TenPercentOwner2025-10-29Sale134,240.0$1.55
MPM BioVentures 2014 (B), L.P.TenPercentOwner2025-10-29Sale134,240.0$1.55
MPM Asset Management Investors BV2014 LLCTenPercentOwner2025-10-29Sale134,240.0$1.55
MPM BioVentures 2014 LLCTenPercentOwner2025-10-29Sale134,240.0$1.55
MPM BioVentures 2014 GP LLCTenPercentOwner2025-10-29Sale134,240.0$1.55
GADICKE ANSBERTTenPercentOwner2025-10-29Sale134,240.0$1.55
MPM ASSET MANAGEMENT LLCTenPercentOwner2025-10-29Sale134,240.0$1.55
MPM BioImpact LLCTenPercentOwner2025-10-29Sale134,240.0$1.55
UBS Oncology Impact Fund L.P.TenPercentOwner2025-10-29Sale134,240.0$1.55
MPM ONCOLOGY INNOVATIONS FUND LPTenPercentOwner2025-10-29Sale134,240.0$1.55
Oncology Impact Fund (Cayman) Management L.P.TenPercentOwner2025-10-29Sale134,240.0$1.55
MPM Oncology Innovations Fund GP LLCTenPercentOwner2025-10-29Sale134,240.0$1.55
EVNIN LUKEDirector2025-10-28Sale44,327.0$1.64
MPM BioVentures 2014, L.P.TenPercentOwner2025-10-28Sale69,068.0$1.64
MPM BioVentures 2014 (B), L.P.TenPercentOwner2025-10-28Sale69,068.0$1.64
MPM Asset Management Investors BV2014 LLCTenPercentOwner2025-10-28Sale69,068.0$1.64
MPM BioVentures 2014 LLCTenPercentOwner2025-10-28Sale69,068.0$1.64
MPM BioVentures 2014 GP LLCTenPercentOwner2025-10-28Sale69,068.0$1.64
GADICKE ANSBERTTenPercentOwner2025-10-28Sale69,068.0$1.64
MPM ASSET MANAGEMENT LLCTenPercentOwner2025-10-28Sale69,068.0$1.64
MPM BioImpact LLCTenPercentOwner2025-10-28Sale69,068.0$1.64
UBS Oncology Impact Fund L.P.TenPercentOwner2025-10-28Sale69,068.0$1.64
MPM ONCOLOGY INNOVATIONS FUND LPTenPercentOwner2025-10-28Sale69,068.0$1.64
Oncology Impact Fund (Cayman) Management L.P.TenPercentOwner2025-10-28Sale69,068.0$1.64
MPM Oncology Innovations Fund GP LLCTenPercentOwner2025-10-28Sale69,068.0$1.64
EVNIN LUKEDirector2025-10-27Sale46,664.0$1.72
MPM BioVentures 2014, L.P.TenPercentOwner2025-10-27Sale72,709.0$1.72
MPM BioVentures 2014 (B), L.P.TenPercentOwner2025-10-27Sale72,709.0$1.72
MPM Asset Management Investors BV2014 LLCTenPercentOwner2025-10-27Sale72,709.0$1.72
MPM BioVentures 2014 LLCTenPercentOwner2025-10-27Sale72,709.0$1.72
MPM BioVentures 2014 GP LLCTenPercentOwner2025-10-27Sale72,709.0$1.72
GADICKE ANSBERTTenPercentOwner2025-10-27Sale72,709.0$1.72
MPM ASSET MANAGEMENT LLCTenPercentOwner2025-10-27Sale72,709.0$1.72
MPM BioImpact LLCTenPercentOwner2025-10-27Sale72,709.0$1.72
UBS Oncology Impact Fund L.P.TenPercentOwner2025-10-27Sale72,709.0$1.72